Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STA... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STATUS FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB + VENETOCLAX IN THE HOVON 141/VISION TRIAL
0
Authors
Aleksandra Urban
20 more
Aleksandra Urban
•
Johanne Hermansen
18 more
•
Sigrid Skånland
Published
August 1, 2023
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
HemaSphere
Topics
Medicine
Cancer Oncology
Internal Medicine
Genetics
Pathology And Forensic Medicine
Show all topics
DOI
10.1097/01.hs9.0000967488.92046.ec
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
HemaSphere
Topics
Medicine
Cancer Oncology
Internal Medicine
Genetics
Pathology And Forensic Medicine
Show all topics
DOI
10.1097/01.hs9.0000967488.92046.ec
License
CC-BY-NC-ND
